Sergio Chimenti
#166,247
Most Influential Person Now
Researcher
Sergio Chimenti's AcademicInfluence.com Rankings
Sergio Chimenticomputer-science Degrees
Computer Science
#9998
World Rank
#10489
Historical Rank
Computational Linguistics
#2493
World Rank
#2518
Historical Rank
Machine Learning
#4521
World Rank
#4572
Historical Rank
Artificial Intelligence
#4879
World Rank
#4943
Historical Rank
Download Badge
Computer Science
Sergio Chimenti's Degrees
- PhD Computer Science Stanford University
- Masters Computer Science University of California, Berkeley
- Bachelors Computer Science University of California, Berkeley
Similar Degrees You Can Earn
Why Is Sergio Chimenti Influential?
(Suggest an Edit or Addition)Sergio Chimenti's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- WHO-EORTC classification for cutaneous lymphomas. (2005) (3669)
- EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer. (1997) (1347)
- Dermoscopy of pigmented skin lesions: results of a consensus meeting via the Internet. (2003) (1099)
- European S3‐Guidelines on the systemic treatment of psoriasis vulgaris (2009) (668)
- Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis. (2015) (620)
- Integrative responses to IL-17 and TNF-α in human keratinocytes account for key inflammatory pathogenic circuits in psoriasis. (2011) (548)
- Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor, in patients with moderate to severe plaque psoriasis: Results of a phase III, randomized, controlled trial (Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis [ESTEEM] 1). (2015) (474)
- Tofacitinib versus etanercept or placebo in moderate-to-severe chronic plaque psoriasis: a phase 3 randomised non-inferiority trial (2015) (332)
- WHO/EORTC classification of cutaneous lymphomas 2005: histological and molecular aspects (2005) (327)
- Dermoscopy of pigmented skin lesions. (2001) (325)
- Treatment of toxic epidermal necrolysis with high-dose intravenous immunoglobulins: multicenter retrospective analysis of 48 consecutive cases. (2003) (324)
- European patient perspectives on the impact of psoriasis: the EUROPSO patient membership survey (2006) (317)
- A classification of psoriasis vulgaris according to phenotype (2007) (278)
- Cytotoxic/natural killer cell cutaneous lymphomas (2003) (240)
- An Italian Study on Psoriasis and Depression (2006) (234)
- Biological therapies in the systemic management of psoriasis: International Consensus Conference (2004) (214)
- Involvement of interleukin-21 in the epidermal hyperplasia of psoriasis (2009) (203)
- Prognostic factors in primary cutaneous B-cell lymphoma: the Italian Study Group for Cutaneous Lymphomas. (2006) (199)
- Impact of Body Mass Index and Obesity on Clinical Response to Systemic Treatment for Psoriasis (2008) (186)
- Granulomatous mycosis fungoides and granulomatous slack skin: a multicenter study of the Cutaneous Lymphoma Histopathology Task Force Group of the European Organization For Research and Treatment of Cancer (EORTC). (2008) (158)
- CLinical experience acquired with the efalizumab (Raptiva®) (CLEAR) trial in patients with moderate‐to‐severe plaque psoriasis: results from a phase III international randomized, placebo‐controlled trial (2006) (154)
- The spectrum of Spitz nevi: a clinicopathologic study of 83 cases. (2005) (153)
- Face-to-face diagnosis vs telediagnosis of pigmented skin tumors: a teledermoscopic study. (1999) (146)
- Dermoscopic diagnosis by a trained clinician vs. a clinician with minimal dermoscopy training vs. computer‐aided diagnosis of 341 pigmented skin lesions: a comparative study (2002) (144)
- Effect of anti-tumor necrosis factor-alpha therapies on body mass index in patients with psoriasis. (2008) (142)
- Pharmacogenetics of psoriasis: HLA‐Cw6 but not LCE3B/3C deletion nor TNFAIP3 polymorphism predisposes to clinical response to interleukin 12/23 blocker ustekinumab (2013) (139)
- Survival rate of antitumour necrosis factor‐α treatments for psoriasis in routine dermatological practice: a multicentre observational study (2013) (135)
- A regulatory feedback loop involving p63 and IRF6 links the pathogenesis of 2 genetically different human ectodermal dysplasias. (2010) (135)
- Adalimumab for severe psoriasis and psoriatic arthritis: an open-label study in 30 patients previously treated with other biologics. (2007) (134)
- Developmental factor IRF6 exhibits tumor suppressor activity in squamous cell carcinomas (2011) (133)
- Teledermoscopy - results of a multicentre study on 43 pigmented skin lesions (2000) (133)
- Three-point checklist of dermoscopy. A new screening method for early detection of melanoma. (2004) (120)
- Identical TCR β-Chain Rearrangements in Streptococcal Angina and Skin Lesions of Patients with Psoriasis Vulgaris1 (2006) (112)
- Oral ponesimod in patients with chronic plaque psoriasis: a randomised, double-blind, placebo-controlled phase 2 trial (2014) (111)
- Three-Point Checklist of Dermoscopy (2004) (109)
- A phase IIIb, multicentre, randomized, double‐blind, vehicle‐controlled study of the efficacy and safety of adalimumab with and without calcipotriol/betamethasone topical treatment in patients with moderate to severe psoriasis: the BELIEVE study (2010) (108)
- Fine mapping of the PSORS4 psoriasis susceptibility region on chromosome 1q21. (2001) (105)
- CD56-positive haematological neoplasms of the skin: a multicentre study of the Cutaneous Lymphoma Project Group of the European Organisation for Research and Treatment of Cancer (2006) (104)
- Unconventional Use of Intense Pulsed Light (2014) (96)
- Psoriasis: from pathogenesis to novel therapeutic approaches. (2011) (93)
- Prospective assessment of body weight and body composition changes in patients with psoriasis receiving anti‐TNF‐α treatment (2011) (89)
- Moderate and severe plaque psoriasis: cost-of-illness study in Italy (2008) (88)
- Is dermoscopy useful for the diagnosis of melanoma? (2001) (84)
- Metabolic abnormalities associated with initiation of systemic treatment for psoriasis: evidence from the Italian Psocare Registry (2013) (83)
- CDKN2a/p16INK4a mutations and lack of p19ARF involvement in familial melanoma kindreds. (1998) (82)
- Imiquimod 5% cream in the treatment of Bowen's disease and invasive squamous cell carcinoma. (2006) (81)
- Cutaneous Manifestations in Patients with Chronic Renal Failure on Hemodialysis (2014) (81)
- Incidence of psoriasis and association with comorbidities in Italy: a 5-year observational study from a national primary care database. (2010) (81)
- Preliminary observations on the use of topical tazarotene to treat basal-cell carcinoma. (1999) (79)
- Scalp psoriasis: European consensus on grading and treatment algorithm (2009) (77)
- IL-6 as a Druggable Target in Psoriasis: Focus on Pustular Variants (2014) (76)
- Concordance between telepathologic diagnosis and conventional histopathologic diagnosis: a multiobserver store-and-forward study on 20 skin specimens. (2002) (76)
- Thymic stromal lymphopoietin links keratinocytes and dendritic cell-derived IL-23 in patients with psoriasis. (2014) (76)
- Diagnosis of pigmented skin lesions by dermoscopy: web‐based training improves diagnostic performance of non‐experts (2003) (76)
- Imiquimod Treatment of Superficial and Nodular Basal Cell Carcinoma: 12‐Week Open‐Label Trial (2005) (75)
- The Role of Tumour Necrosis Factor in the Pathogenesis of Immune-Mediated Diseases (2014) (74)
- Cutaneous involvement in lymphoblastic lymphoma (1999) (74)
- Different applications of monochromatic excimer light in skin diseases. (2009) (73)
- The use of topical diphenylcyclopropenone for the treatment of extensive alopecia areata. (2001) (73)
- The use of chemical peelings in the treatment of different cutaneous hyperpigmentations. (1999) (70)
- Microsatellite instability and loss of heterozygosity in melanoma. (1995) (69)
- Treatment of vitiligo with the 308 nm excimer laser (2004) (69)
- Identical TCR beta-chain rearrangements in streptococcal angina and skin lesions of patients with psoriasis vulgaris. (2006) (69)
- Tazarotene 0·1% gel for psoriasis of the fingernails and toenails: an open, prospective study (2003) (68)
- Central white scarlike patch: a dermatoscopic clue for the diagnosis of dermatofibroma. (2000) (68)
- Efficacy and Safety of Subcutaneous Anti-Tumor Necrosis Factor-Alpha Agents, Etanercept and Adalimumab, in Elderly Patients Affected by Psoriasis and Psoriatic Arthritis: An Observational Long-Term Study (2012) (67)
- Topical treatment of basal cell carcinoma with tazarotene: a clinicopathological study on a large series of cases (2004) (65)
- Adalimumab in the Treatment of Immune-Mediated Diseases (2014) (63)
- The tumor suppressor activity of IKKα in stratified epithelia is exerted in part via the TGF-β antiproliferative pathway (2008) (62)
- Vitiligo treatment with monochromatic excimer light and tacrolimus: results of an open randomized controlled study. (2012) (62)
- Dermoscopic variability of basal cell carcinoma according to clinical type and anatomic location (2015) (61)
- Remission and time of resolution of nail psoriasis during infliximab therapy. (2005) (61)
- A p38-dependent pathway regulates ΔNp63 DNA binding to p53-dependent promoters in UV-induced apoptosis of keratinocytes (2005) (58)
- Dermoscopic and histopathologic diagnosis of equivocal melanocytic skin lesions (2002) (58)
- Anti-TNF Agents as Therapeutic Choice in Immune-Mediated Inflammatory Diseases: Focus on Adalimumab (2014) (57)
- Juvenile psoriasis and its clinical management: a European expert group consensus (2010) (55)
- IKKalpha is a p63 transcriptional target involved in the pathogenesis of ectodermal dysplasias. (2009) (55)
- Re: MC1R, ASIP, and DNA repair in sporadic and familial melanoma in a Mediterranean population. (2006) (53)
- PsAPASH: a new syndrome associated with hidradenitis suppurativa with response to tumor necrosis factor inhibition. (2015) (53)
- Efficacy of switching between tumor necrosis factor-alfa inhibitors in psoriasis: results from the Italian Psocare registry. (2014) (52)
- Differentiation between pigmented Spitz naevus and melanoma by digital dermoscopy and stepwise logistic discriminant analysis (2001) (51)
- Monochromatic excimer light 308 nm in monotherapy and combined with topical khellin 4% in the treatment of vitiligo: a controlled study (2009) (51)
- Regional distribution of psoriasis in Italy (2008) (51)
- Use of recombinant interferon alfa-2b in the treatment of basal cell carcinoma. (1995) (50)
- Interobserver Agreement on Dermoscopic Features of Pigmented Basal Cell Carcinoma (2002) (49)
- Contribution of melanocortin-1 receptor gene variants to sporadic cutaneous melanoma risk in a population in central Italy: a case–control study (2006) (49)
- Etanercept for the treatment of severe childhood psoriasis (2006) (49)
- Graham Little–Piccardi–Lassueur syndrome: effective treatment with cyclosporin A (2001) (49)
- −174G/C IL-6 gene promoter polymorphism predicts therapeutic response to TNF-&agr; blockers (2012) (49)
- Melanocytic nevi of the breast: a histologic case‐control study (2004) (49)
- Safety of anti-TNFα agents in the treatment of psoriasis and psoriatic arthritis (2012) (49)
- Cutaneous metastatic breast carcinoma (2000) (49)
- Efficacy and safety of adalimumab in patients with psoriasis previously treated with anti‐tumour necrosis factor agents: subanalysis of BELIEVE (2011) (49)
- Exclusion of CARD15/NOD2 as a candidate susceptibility gene to psoriasis in the Italian population. (2002) (48)
- Dermoscopic classification of Spitz/Reed nevi. (2002) (48)
- Risk factors of hypertension, diabetes and obesity in Italian psoriasis patients: a survey on socio-demographic characteristics, smoking habits and alcohol consumption. (2009) (48)
- Influence and Variation of the Body Mass Index in Patients Treated with Etanercept for Plaque-Type Psoriasis (2009) (47)
- Efficacy and Safety of Etanercept in Psoriasis after Switching from Other Treatments (2009) (47)
- Efficacy of monochromatic excimer laser radiation (308 nm) in the treatment of early stage mycosis fungoides (2004) (47)
- Recommendations for the use of etanercept in psoriasis: a European dermatology expert group consensus (2006) (47)
- Psoriatic arthritis and CARD15 gene polymorphisms: no evidence for association in the Italian population. (2004) (46)
- Fumaric acid esters in the treatment of psoriasis: an Italian experience (2004) (45)
- Childhood Nail Psoriasis: A Useful Treatment with Tazarotene 0.05% (2007) (45)
- Biosimilars for psoriasis: worldwide overview of regulatory guidelines, uptake and implications for dermatology clinical practice (2017) (44)
- Fate of UVB-induced p53 mutations in SKH-hr1 mouse skin after discontinuation of irradiation: relationship to skin cancer development (2005) (44)
- IL12B (p40) Gene Polymorphisms Contribute to Ustekinumab Response Prediction in Psoriasis (2015) (44)
- Localized morphea treated with imiquimod 5% and dermoscopic assessment of effectiveness (2009) (44)
- Loss of CDKN2A and p14ARF expression occurs frequently in human nonmelanoma skin cancers (2007) (44)
- Histological features used in the diagnosis of melanoma are frequently found in benign melanocytic naevi (2005) (44)
- A 308‐nm monochromatic excimer light in the treatment of palmoplantar psoriasis (2006) (44)
- Characterization of the loricrin (LOR) gene as a positional candidate for the PSORS4 psoriasis susceptibility locus (2004) (43)
- New insights into the pathogenesis of cutaneous autoimmune disorders. (2012) (43)
- Evidence of increased apoptosis and reduced proliferation in basal cell carcinomas treated with tazarotene. (2004) (43)
- Coexpression of Bone Sialoprotein (BSP) and the Pivotal Transcriptional Regulator of Osteogenesis, Cbfa1/Runx2, in Malignant Melanoma (2003) (42)
- Emerging applications of nanomedicine in dermatology (2013) (42)
- Systemic therapy of primary cutaneous B-cell lymphoma, marginal zone type, with rituximab, a chimeric anti-CD20 monoclonal antibody. (2001) (42)
- Treatment of erythrodermic psoriasis with etanercept (2006) (42)
- IL-21 Promotes Skin Recruitment of CD4+ Cells and Drives IFN-γ–Dependent Epidermal Hyperplasia (2011) (41)
- Dermoscopy of pigmented skin lesions (Part II). (2001) (41)
- Analysis of health care and actual needs of patients with psoriasis: a survey on the Italian population (2007) (40)
- Complete Resolution of Erythrodermic Psoriasis in an HIV and HCV Patient Unresponsive to Antipsoriatic Treatments after Highly Active Antiretroviral Therapy (Ritonavir, Atazanavir, Emtricitabine, Tenofovir) (2012) (40)
- Teledermatology: Just Cool or a Real Tool? (2005) (40)
- Clobetasol propionate foam 0.05% as a novel topical formulation for plaque‐type and scalp psoriasis (2007) (40)
- Recommendations for the Long-Term Treatment of Psoriasis with Infliximab: A Dermatology Expert Group Consensus (2008) (39)
- Topical Treatment of Actinic Keratoses with Piroxicam 1% Gel (2010) (39)
- Co-Localization of Susceptibility Loci for Psoriasis (PSORS4) and Atopic Dermatitis (ATOD2) on Human Chromosome 1q21 (2006) (39)
- An occlusive dressing containing betamethasone valerate 0.1% for the treatment of prurigo nodularis (2010) (39)
- Prevention of dermatologic side effects of bimatoprost 0.03% topical therapy. (2006) (39)
- HLA-C*06 and response to ustekinumab in Caucasian patients with psoriasis: Outcome and long-term follow-up. (2016) (38)
- Short Contact Therapy with Tazarotene in Psoriasis Vulgaris (2006) (38)
- New topical treatments for psoriasis (2014) (38)
- Efficacy and maintenance strategies of two-compound formulation calcipotriol and betamethasone dipropionate gel (Xamiol® gel) in the treatment of scalp psoriasis: results from a study in 885 patients (2014) (38)
- Widespread microsatellite instability in sebaceous tumours of patients with the Muir‐Torre syndrome (1997) (37)
- Monochromatic excimer light (308 nm) in the treatment of prurigo nodularis (2008) (37)
- Constitutional and environmental risk factors for cutaneous melanoma in an Italian population. A case–control study (2004) (37)
- The use of high-dose immunoglobulin in the treatment of pyoderma gangrenosum (2001) (37)
- Latent tuberculosis infection in patients with chronic plaque psoriasis: evidence from the Italian Psocare Registry (2015) (37)
- Impact of dermoscopy on the clinical management of pigmented skin lesions. (2002) (36)
- A new therapeutic for the treatment of moderate-to-severe plaque psoriasis: apremilast (2016) (35)
- Severe acne successfully treated with etanercept. (2006) (35)
- A biological approach in a patient with psoriasis and bullous pemphigoid associated with losartan therapy (2008) (35)
- Pyoderma vegetans and ulcerative colitis (2001) (35)
- Tofacitinib for the treatment of moderate-to-severe psoriasis (2015) (35)
- Long‐term efficacy of adalimumab in generalized pustular psoriasis (2008) (34)
- One‐year safety and efficacy of ustekinumab and results of dose adjustment after switching from inadequate methotrexate treatment: the TRANSIT randomized trial in moderate‐to‐severe plaque psoriasis (2014) (34)
- Efficacy, safety and quality of life of calcipotriol/betamethasone dipropionate (Dovobet®) versus calcipotriol (Daivonex®) in the treatment of psoriasis vulgaris: A randomized, multicentre, clinical trial (2007) (34)
- AISI: A New Disease Severity Assessment Tool for Hidradenitis Suppurativa. (2015) (34)
- Long-term ustekinumab treatment for refractory type I pityriasis rubra pilaris. (2013) (33)
- Efficacy of monochromatic excimer light (308 nm) in the treatment of atopic dermatitis in adults and children. (2008) (33)
- Cross-talks in the p53 family: deltaNp63 is an anti-apoptotic target for deltaNp73alpha and p53 gain-of-function mutants. (2006) (33)
- Molecular basis of basal cell carcinoma: Analysis of differential gene expression by differential display PCR and expression array (2003) (33)
- Profile of certolizumab and its potential in the treatment of psoriatic arthritis (2013) (32)
- Diagnosis and categorization of acral melanocytic lesions using teledermoscopy (2004) (32)
- Cross-Talks in the p53 Family: ΔNp63 is an Anti-Apoptotic Target for ΔNp73α and p53 Gain of Function Mutants (2006) (32)
- Prevalence and risk factors of actinic keratosis in patients attending Italian dermatology clinics (2017) (32)
- Apremilast for the treatment of psoriasis (2015) (32)
- Efalizumab (2011) (31)
- Psoriasis, from pathogenesis to therapeutic strategies: IL-21 as a novel potential therapeutic target. (2012) (31)
- Superficial Black Network: An Additional Dermoscopic Clue for the Diagnosis of Pigmented Spindle and/or Epithelioid Cell Nevus (2001) (31)
- Long‐term treatment of plaque psoriasis with efalizumab: an Italian experience (2007) (31)
- Role of Contrast-Enhanced Ultrasound in Early Diagnosis of Psoriatic Arthritis (2009) (31)
- Identification of four novel melanocortin 1 receptor (MC1R) gene variants in a Mediterranean population (2003) (31)
- UV fingerprint CDKN2a but no p14ARF mutations in sporadic melanomas. (1999) (30)
- Jumping into the future using teledermoscopy. (2002) (30)
- Psoriasis Phenotype in Inflammatory Bowel Disease: A Case-Control Prospective Study. (2015) (30)
- Long-lasting remission of pemphigus vulgaris treated with rituximab. (2006) (30)
- Dose adjustment of biologic therapies for psoriasis in dermatological practice: a retrospective study (2017) (30)
- Feasibility of a Two‐Step Teledermatologic Approach for the Management of Patients with Multiple Pigmented Skin Lesions (2007) (30)
- TNF-α antagonists and nail psoriasis: an open, 24-week, prospective cohort study in adult patients with psoriasis (2013) (30)
- The Impact of Methodological Approaches for Presenting Long-Term Clinical Data on Estimates of Efficacy in Psoriasis Illustrated by Three-Year Treatment Data on Infliximab (2010) (30)
- Type III juvenile pityriasis rubra pilaris: a successful treatment with infliximab (2007) (30)
- Lymphoblastic lymphoma of the pre-B phenotype with cutaneous presentation. (1997) (29)
- Interobserver reproducibility of histological features in cutaneous malignant melanoma (2005) (29)
- Etanercept at Different Dosages in the Treatment of Generalized Pustular Psoriasis: A Case Series (2008) (29)
- Allele-specific cytokine responses at the HLA-C locus, implications for psoriasis (2011) (28)
- Mucosal involvement in a patient with lymphomatoid papulosis. (2001) (28)
- Juvenile colloid milium (1989) (28)
- Role of Th17 in the pathogenesis of cutaneous inflammatory diseases. (2012) (28)
- Long-term use of a new topical formulation containing piroxicam 0.8% and sunscreen: efficacy and tolerability on actinic keratosis. A proof of concept study (2016) (27)
- Calcipotriene/betamethasone in the treatment of psoriasis: a review article (2009) (27)
- Safety and efficacy study on etanercept in patients with plaque psoriasis (2005) (27)
- Real‐life 9‐year experience with adalimumab in psoriasis and psoriatic arthritis: results of a single‐centre, retrospective study (2017) (27)
- CDKN2A and MC1R mutations in patients with sporadic multiple primary melanoma. (2004) (27)
- Management of Non-Melanoma Skin Cancer in Solid Organ Transplant Recipients (2014) (25)
- Methyl aminolaevulinate photodynamic therapy for the treatment of hidradenitis suppurativa and pilonidal cysts (2009) (25)
- Prevalence of Past and Reactivated Viral Infections and Efficacy of Cyclosporine A as Monotherapy or in Combination in Patients with Psoriatic Arthritis—Synergy Study: A Longitudinal Observational Study (2014) (25)
- Long‐term efficacy of etanercept in hidradenitis suppurativa (2008) (25)
- Local treatment of chronic cutaneous leg ulcers with recombinant human granulocyte‐macrophage colony‐stimulating factor (2002) (24)
- Relation between animal-type melanoma and reduced nuclear expression of glutathione S-transferase pi. (2009) (24)
- Immunologic Biomarkers for Clinical and Therapeutic Management of Psoriasis (2014) (24)
- Hydroxyurea associated with concomitant occurrence of diffuse longitudinal melanonychia and multiple squamous cell carcinomas in an elderly subject. (2008) (24)
- Family history of psoriasis and age at disease onset in Italian patients with psoriasis (2007) (24)
- The Cost Effectiveness of Biologic Therapy for the Treatment of Chronic Plaque Psoriasis in Real Practice Settings in Italy (2014) (23)
- Genetic variations in IL6 and IL12B decreasing the risk for psoriasis. (2013) (23)
- Keratoderma hereditarium mutilans (Vohwinkel's syndrome) associated with congenital deaf‐mutism (1995) (23)
- Efficacy and tolerability of 5-aminolevulinic acid 0.5% liposomal spray and intense pulsed light in wrinkle reduction of photodamaged skin (2011) (23)
- Cerebral cavernomas in a family with multiple cutaneous and uterine leiomyomas associated with a new mutation in the fumarate hydratase gene. (2007) (23)
- The role of MT2 and anti‐bcl‐2 protein antibodies in the differentiation of benign from malignant cutaneous infiltrates of B‐lymphocytes with germinal center formation (1996) (22)
- Transition to ustekinumab in patients with moderate‐to‐severe psoriasis and inadequate response to methotrexate: a randomized clinical trial (TRANSIT) (2014) (22)
- Gingival metastasis as first sign of an undifferentiated carcinoma of the lung. (1994) (22)
- Analysis of microsatellite instability and loss of heterozygosity in keratoacanthoma (1997) (21)
- Does metabolic syndrome influence psoriasis? (2008) (21)
- Angiosarcoma of the face and scalp. A case report with complete spontaneous regression. (1991) (21)
- Small molecules and antibodies for the treatment of psoriasis: a patent review (2010–2015) (2016) (21)
- High‐dose initiation of etanercept in psoriatic arthritis and plaque psoriasis: Efficacy, safety and impact on patients' quality of life (2006) (20)
- Tazarotene as alternative topical treatment for onychomycosis (2015) (20)
- A cost–utility analysis of etanercept for the treatment of moderate-to-severe psoriasis in Italy (2009) (20)
- Reduced expression of CDKN2a/p16INK4a in mycosis fungoides (1999) (20)
- Etanercept provides an effective, safe and flexible short- and long-term treatment regimen for moderate-to-severe psoriasis: a systematic review of current evidence (2013) (20)
- Effect of calcipotriol on etanercept partial responder psoriasis vulgaris and psoriatic arthritis patients. (2009) (20)
- How to manage infections in the era of biologics? (2008) (19)
- Hidradenitis suppurativa: guidelines of the Italian Society of Dermatology and Venereology (SIDeMaST) for the use of anti-TNF-α agents. (2015) (19)
- Bullous dermatomyositis: a marker of poor prognosis and aggressive internal malignancy? (2008) (19)
- Microabrasion Versus Microabrasion Followed by 15% Trichloroacetic Acid for Treatment of Cutaneous Hyperpigmentations in Adult Females (2003) (19)
- Evolution of and Risk Factors for Psychological Distress in Patients with Psoriasis: The Psychae Study (2010) (19)
- Superficial and nodular basal cell carcinomas treated with an immune response modifier: a report of seven patients (2003) (19)
- Tofacitinib for the treatment of psoriasis (2016) (19)
- Basal cell carcinoma: clinical and pathological features. (2015) (19)
- The impact of biologic therapy in chronic plaque psoriasis from a societal perspective: an analysis based on Italian actual clinical practice (2015) (18)
- Current psoriasis treatments in an Italian population and their association with socio‐demographical and clinical features (2012) (18)
- Numerical aberrations of chromosome 7 detected in 15 μm paraffin‐embedded tissue sections of primary cutaneous melanomas by fluorescence in situ hybridization and confocal laser scanning microscopy (1997) (18)
- Specific challenges in the management of subungual melanoma (2011) (18)
- Unusually large cutaneous metastases of renal cell carcinoma. (2001) (17)
- Metastatic Crohn's Disease of the Forehead (2002) (17)
- Dermoscopic Monitoring of Tazarotene Treatment of Superficial Basal Cell Carcinoma (2005) (17)
- Biosimilars for psoriasis: clinical studies to determine similarity (2017) (17)
- Melanoma‐associated markers expression in blood: MUC‐18 is associated with advanced stages in melanoma patients (2009) (16)
- Treatment of trachyonychia with tazarotene (2005) (16)
- Actinic keratosis treated with an immune response modifier: a case report of six patients (2003) (16)
- Remission of Psoriatic Arthritis after Etanercept Discontinuation: Analysis of Patients' Clinical Characteristics Leading to Disease Relapse (2013) (16)
- Sequential molecular analysis of circulating MCAM/MUC18 expression: a promising disease biomarker related to clinical outcome in melanoma (2014) (16)
- Consensus on the use of the fixed combination calcipotriol/betamethasone dipropionate in the treatment of plaque psoriasis. (2012) (16)
- The p73 gene is an anti-tumoral target of the RARβ/γ-selective retinoid tazarotene (2004) (16)
- The nitrobenzoxadiazole derivative MC3181 blocks melanoma invasion and metastasis (2017) (16)
- Italian Euromelanoma Day Screening Campaign (2005–2007) and the planning of melanoma screening strategies (2012) (15)
- What Happened after the Clinical Trials: Long-Term Safety and Efficacy of Ustekinumab in Daily Clinical Practice (2014) (15)
- Glycolic acid and its use in dermatology (1995) (15)
- Pharmacodynamic assessment of apremilast for the treatment of moderate-to-severe plaque psoriasis (2016) (15)
- Ustekinumab Treatment of Erythrodermic Psoriasis Occurring after Physical Stress: A Report of Two Cases (2013) (15)
- Is subcorneal pustular dermatosis of Sneddon and Wilkinson an entity sui generis? (1981) (15)
- Continuous Treatment of Plaque-Type Psoriasis with Etanercept: An Observational Long-Term Experience (2010) (15)
- Infliximab therapy induces increased polyclonality of CD4+CD25+ regulatory T cells in psoriasis (2009) (15)
- Detection of Epstein‐Barr virus in cutaneous and lymph nodal anaplastic large cell lymphomas (Ki‐l+) (1995) (15)
- Differential management of mild-to-severe psoriasis with biologic drugs: An Italian Delphi consensus expert panel (2015) (15)
- Bioelectrical impedance analysis to define an excess of body fat: evaluation in patients with psoriasis (2017) (14)
- Cost-effectiveness analysis of topical treatments for actinic keratosis in the perspective of the Italian health care system. (2010) (14)
- The role of antinuclear autoantibodies in patients with psoriasis treated with anti-tumor necrosis factor-alpha agents: a retrospective long-term study. (2012) (14)
- Adalimumab for the treatment of severe psoriasis and psoriatic arthritis (2008) (14)
- Efficacy and Safety of Efalizumab in Patients with Moderate-to-Severe Plaque Psoriasis Resistant to Previous Anti-Psoriatic Treatment: Results of a Multicentre, Open-label, Phase IIIb/IV Trial (2010) (14)
- The GENDER ATTENTION Observational Study: Gender and Hormonal Status Differences in the Incidence of Adverse Events During Cyclosporine Treatment in Psoriatic Patients (2017) (14)
- Granulomatous Mycosis Fungoides and Granulomatous Slack Skin (2008) (14)
- Treatment Adherence to Different Etanercept Regimens, Continuous vs. Intermittent, in Patients Affected by Plaque‐Type Psoriasis (2014) (13)
- Long-term experience with etanercept in psoriatic arthritis patients: A 3-year observational study (2009) (13)
- Frequency of melanocytic nevi in psoriatic patients is related to treatment and not to disease severity. (2013) (13)
- Successful treatment of multiple filiform facial warts with imiquimod 5% cream in a patient infected by human immunodeficiency virus (2003) (13)
- Treatment of lentigo maligna with tazarotene 0.1% gel. (2004) (13)
- Erysipeloid cutaneous metastasis from bladder carcinoma. (2007) (13)
- Efficacy evaluation of an oil-in-water emulsion (Dermoflan) in atopic dermatitis. (2002) (12)
- Imiquimod 5% cream in the treatment of basal cell carcinoma” (2002) (12)
- Zosteriform metastasis of occult bronchogenic carcinoma. (2000) (12)
- Rhodamine intense pulsed light versus conventional intense pulsed light for facial telangiectasias (2016) (11)
- Staphylococcal Scalded Skin Syndrome: Criteria for Differential Diagnosis from Lyell's Syndrome. Two Cases in Adult Patients. (2006) (11)
- Progressive late-onset of cutaneous angiomatosis as possible sign of cerebral cavernous malformations. (2013) (11)
- HIV‐associated primary cutaneous anaplastic large cell lymphoma: a clinicopathological subset with more aggressive behavior? Case report and review of the literature (2012) (11)
- Severe erytrodermic psoriasis in child twins: from clinical-pathological diagnosis to treatment of choice through genetic analyses: two case reports (2014) (11)
- Phrynoderma: a cutaneous sign of an inadequate diet (2007) (11)
- Topical use of calcitriol 3 µg/g ointment in the treatment of mild‐to‐moderate psoriasis: results from an open‐label study (2005) (11)
- Dermoscopic features of cutaneous local recurrent melanoma. (2000) (11)
- Infliximab in Psoriasis and Psoriatic Arthritis (2013) (11)
- Therapeutic options in an immunocompromised patient with pemphigus vulgaris: potential interest of plasmapheresis and extracorporeal photochemotherapy. (2008) (11)
- Atopic dermatitis and dental manifestations. (2017) (11)
- Effective topical agents and emerging perspectives in the treatment of psoriasis (2012) (11)
- Dermoscopy as an adjuvant tool for detecting skin leiomyomas in patient with uterine fibroids and cerebral cavernomas (2014) (11)
- Adalimumab in the treatment of plaque-type psoriasis and psoriatic arthritis (2013) (10)
- Disseminated pagetoid reticulosis presenting as cytotoxic CD4/CD8 double negative cutaneous T-cell lymphoma. (2002) (10)
- Apheresis in the treatment of recalcitrant atopic dermatitis: case series and review of the literature (2014) (10)
- Detection of Adalimumab and Anti‐Adalimumab Levels by ELISA: Clinical Considerations (2014) (10)
- Adalimumab for the treatment of severe psoriasis and psoriatic arthritis. (2008) (10)
- Cutaneous epithelioid cell histiocytoma: immunohistochemical and ultrastructural findings suggesting endothelial origin. (1997) (10)
- Alice, Eloi, Magali and Robert: the lives of four patients with psoriasis and the therapeutic approaches of eight European experts (2009) (10)
- Aphthous, celiac disease and other dental disorders in childhood. (2016) (10)
- Histopathologic Interobserver Agreement on the Diagnosis of Melanocytic Skin Lesions with Equivocal Dermoscopic Features: A Pilot Study (2000) (10)
- Quality of life and patient benefit following transition from methotrexate to ustekinumab in psoriasis (2017) (10)
- Efficacy of Short-Term Cyclosporine Treatment to Control Psoriasis-Related Events during Efalizumab Therapy (2008) (9)
- Infliximab in the treatment of plaque type psoriasis (2009) (9)
- Urticaria associated with hyper-IgE in a patient with psoriasis undergoing treatment with efalizumab. (2009) (9)
- Consensus on the use of cyclosporine in dermatological practice. Italian Consensus Conference. (2014) (9)
- Influence of body mass index and weight on etanercept efficacy in patients with psoriasis: A retrospective study (2016) (9)
- Combination therapy with etanercept in psoriasis: Retrospective analysis of efficacy and safety outcomes from real-life practice (2016) (9)
- Clinical Trial on Aveeno Skin Relief Moisturizing Lotion in patients with itching accompanied by skin lesions and xerosis (2005) (9)
- Peculiar clinical and dermoscopic remission pattern following imiquimod therapy of basal cell carcinoma in seborrhoeic areas of the face (2009) (9)
- Topical lactoferrin can improve stable psoriatic plaque. (2014) (9)
- Ichthyosiform mycosis fungoides: a neoplastic acquired ichthyosis. (2007) (9)
- Patients with Moderate to Severe Plaque Psoriasis: One Year after the European Medicines Agency Recommendation of Efalizumab Suspension (2011) (9)
- Health-related quality of life in psoriasis: an analysis of Psocare project patients. (2011) (9)
- Trimethoprim-sulfamethoxazole induced erythrodermic psoriasis. (2008) (9)
- Evaluation of Clinical and Ultrasonographic Parameters in Psoriatic Arthritis Patients Treated with Adalimumab: A Retrospective Study (2012) (9)
- Use of biological drugs in patients with psoriasis and psoriatic arthritis in Italy: Results from the PSONG survey (2018) (9)
- Etanercept provides a more physiological approach in the treatment of psoriasis (2008) (9)
- "Clown nose" as a first manifestation of lung carcinoma. (1997) (8)
- Cerebriform plantar hyperplasia: the clinico-pathological hallmark of Proteus syndrome. (2011) (8)
- Effects of TNF-α and IL-1β on the Activation of Genes Related to Inflammatory, Immune Responses and Cell Death in Immortalized Human HaCat Keratinocytes (2010) (8)
- Mobile Phones: A Role in Teaching Dermatology? (2010) (8)
- Sentinel Lymphadenectomy in Cutaneous Melanoma (2002) (8)
- Kaposi's sarcoma in a patient treated with imatinib mesylate for chronic myeloid leukemia. (2009) (8)
- Psoriasis, Kaposi’s Sarcoma and Hodgkin’s Disease in a Patient with Down’s Syndrome (2004) (8)
- "Familial" generalized argyria. (2006) (8)
- Exaggerated Imiquimod Application Site Reactions in the Context of Systemic Tumor Necrosis Factor-Alpha Inhibition: More Than a Coincidental Occurrence? (2011) (8)
- Golimumab in Patients Affected by Moderate to Severe Psoriatic Arthritis: An Open-Label Study in Thirty-Two Patients Previously Treated with Other Biologics (2013) (8)
- Double-blind, within-patient, randomized, clinical trial comparing fluorine-synthetic fiber socks with standard cotton socks in improving plantar psoriasis (2014) (7)
- Ink spot lentigo arising on naevus spilus simulating melanoma. (2004) (7)
- Hypoepiluminescence Microscopy of Pigmented Skin Lesions: New Approach to Improve Recognition of Dermoscopic Structures (2006) (7)
- Usefulness of QuantiFERON®-TB Gold test in psoriatic patients under treatment with tumour necrosis factor blockers (2014) (7)
- Treatment of occupational koilonychia with tazarotene gel. (2003) (7)
- Acanthoma fissuratum (1991) (7)
- Increased levels of IL‐17 in tear fluid of moderate‐to‐severe psoriatic patients is reduced by adalimumab therapy (2016) (7)
- Use of Recombinant Interferon-α-2A in the Treatment of Cutaneous Lymphomas of T- and B-Cell Lineage (1994) (7)
- Is there an association between topiramate and granuloma annulare? (2010) (7)
- Treatment of Folliculitis with Monochromatic Excimer Light (308 nm) (2008) (7)
- Chronic mucocutaneous candidiasis and alopecia areata as cutaneous expressions of autoimmune polyglandular syndrome type I. (2002) (7)
- Green sweating spots on hands and feet: unusual expression of hyperbilirubinemia. (2006) (7)
- Basosquamous cell carcinoma with massive cranial osteolysis (2003) (7)
- Betamethasone valerate dressing is non-inferior to calcipotriol–betamethasone dipropionate ointment in the treatment of patients with mild-to-moderate chronic plaque psoriasis: results of a randomized assessor-blinded multicentre trial (2013) (6)
- Dermoscopy coming of age (2006) (6)
- Imiquimod for restoring local immunity in a renal transplant patient with persistent keratoacanthoma. (2008) (6)
- From patients’ needs to treatment outcomes in psoriasis: Results from the ‘pSORRIDI’ experience (2016) (6)
- Linear psoriasis following the typical distribution of the sciatic nerve. (2015) (6)
- Acute onset disseminated superficial porokeratosis heralding diffuse large B-cell lymphoma. (2008) (6)
- Recent patents and new strategies in the treatment of psoriasis. (2006) (6)
- Granulomatous mycosis fungoides responsive to gemcitabine. (2002) (6)
- Quality of life of psoriatic patients evaluated by a new psychometric assessment tool: PsoDisk (2015) (6)
- Clinical Markers Predictive of Primary Inefficacy: A “Real Life” Retrospective Study in Psoriatic Patients Treated with Etanercept (2014) (6)
- Lack of efficacy of imiquimod in patients with basal cell carcinoma previously treated with rituximab for B cell lymphoma: two case reports (2016) (6)
- Bowenoid papulosis and invasive Bowen's disease: a multidisciplinary approach. (2013) (6)
- Etanercept, childhood and long-term safety: a case of five years treatment. (2011) (6)
- The significance of the development of antinuclear antibodies during infliximab treatment. (2013) (6)
- Classification for Primary Cutaneous Lymphomas : A Proposal From the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer (1997) (5)
- Chronically sun-damaged melanomas express low levels of nuclear glutathione-S-transferase-π: an epidemiological and clinicopathological study in Italy. (2015) (5)
- Desloratadine 5 mg once daily improves quality of life in chronic idiopathic urticaria (2006) (5)
- Benign dermoscopic features in melanoma (2014) (5)
- Randomized, Within-Patient, Clinical Trial Comparing Fluorine-Synthetic Fiber Socks with Standard Cotton Socks in Improving Plantar Pustulosis (2014) (5)
- PSORS2 Markers Are Not Associated with Psoriatic Arthritis in the Italian Population (2006) (5)
- Cutaneous eyebrow metastasis in a patient with primary gastric adenocarcinoma. (1994) (5)
- Combination of low-dosage cyclosporine and topical pimecrolimus in severe atopic dermatitis with chronic hepatitis B. (2008) (5)
- Dermatitis artefacta in sporadic sclerodermoid hepatitis C virus‐associated porphyria cutanea tarda (2009) (5)
- Multiple microsatellite alterations on chromosome 9 in neurofibromas of NF-1 patients. (1997) (5)
- HLA-C*18:01: A Rare Allele in the European Caucasian Population Coinciding with Difficult-to-Treat Plaque Psoriasis (2016) (5)
- Expression of c-myc in cutaneous lymphomas and pseudolymphomas. (1991) (5)
- The first skin cancer screening day at the Italian parliament: a Euromelanoma initiative (2015) (5)
- Confocal reflectance microscopy in pityriasis rubra pilaris. (2013) (5)
- HLA-Cw6 allele confers sensitivity to efalizumab treatment in psoriasis (2008) (5)
- Use of Vitamins and their Derivates in the Treatment of Cutaneous Disorders (2013) (5)
- Pilotropic Mycosis fungoides (1999) (4)
- UVA1 Laser in the Treatment of Vitiligo. (2016) (4)
- Dermatomyositis associated with ovarian transitional cell carcinoma. (2001) (4)
- Genetic Markers for Cardiovascular Disease in Psoriasis: The Missing Piece (2014) (4)
- The p73 gene is an anti-tumoral target of the RARbeta/gamma-selective retinoid tazarotene. (2004) (4)
- Efficacy and safety of long-term infliximab therapy in moderate to severe psoriasis and psoriatic arthritis (2006) (4)
- Malignant melanoma of the oral cavity. (1981) (4)
- Immunocytochemical study of a trabecular carcinoma of the skin (Merkel cell tumor). Case report. (1986) (4)
- Consecutive use of different biological therapies in the treatment of psoriasis (2007) (4)
- Ustekinumab in the treatment of psoriasis (2015) (4)
- New therapeutic approaches in the treatment of anogenital lichen sclerosus: does photodynamic therapy represent a novel option? (2017) (3)
- Prevalence and Management of Panic Attacks during Infliximab Infusion in Psoriatic Patients (2012) (3)
- Skin diseases in Europe. Teledermatology. (2009) (3)
- Cyclosporine: a novel therapeutic approach for Burning Mouth Syndrome. (2016) (3)
- Why 3 mg/kg instead of 5 mg/kg of infliximab should work in psoriatic arthritis? (2009) (3)
- Efficacy of cyclosporine A as monotherapy in patients with psoriatic arthritis: a subgroup analysis of the SYNERGY Study. (2017) (3)
- Granuloma annulare: a case treated with infliximab successfully. (2017) (3)
- Relapsed actinic keratosis evaluation: an observational Italian multicenter prospective study. Does gender have a role? (2014) (3)
- Familial generalized argyria. Commentary (2006) (3)
- Efficacy of Efalizumab in Psoriasis Patients Previously Treated with Tumour Necrosis Factor Blockers (2009) (3)
- Isolated B-cell lymphoma of the skin. (1984) (3)
- A 2-Year History of an Asymptomatic Scalp Nodule—Quiz Case (2003) (3)
- Quality of life in patients with plaque psoriasis treated with biologic therapies (2013) (3)
- High density cholesterol level as predictor of clinical response to anti-TNF-alpha therapy in psoriatic patients. (2013) (3)
- Entecavir and intermittent etanercept therapy in a patient with concurrent hepatitis B virus infection and psoriasis. (2013) (3)
- ‘Face-to-face’ versus remote diagnosis of 66 pigmented skin tumors — a teledermatoscopic study (1998) (2)
- A 2-year history of an asymptomatic scalp nodule. (2003) (2)
- AB0942 Efficacy and safety of subcutaneous anti-TNF alpha, etanercept and adalimumab, in elderly patients affected by psoriasis and psoriatic arthritis: An observational long term study (2013) (2)
- [New functions and applications of vitamin D in internal medicine]. (2012) (2)
- Ustekinumab for treatment of plaque psoriasis in a patient with Down syndrome. (2012) (2)
- Dysplastic nevi: objective evaluation using digital epiluminescence microscopy (1997) (2)
- Radiologically significant joint improvement in a patient affected by psoriatic arthritis treated with adalimumab. (2009) (2)
- Eruptive xanthomas and pancretitis: clinical, dermatoscopy, confocal and pathological correlation. (2017) (2)
- Cyclosporine in psoriasis: comparison of a 25-year real-world Italian experience to current European guidelines. (2016) (2)
- "Bathing trunk" eruption of papules and nodules in a young woman. Eruptive disseminated Spitz naevi. (2011) (2)
- A nodule on the forearm of a patient with Hodgkin disease. (2001) (2)
- Therapeutic approaches in psoriasis: a post-hoc analysis of the PSYCHAE study from a gender point of view (2014) (2)
- “Face-to-face” versus remote diagnosis of 66 pigmented skin tumors — A teledermatoscopic study (1998) (2)
- CASE REPORTS AND LITERATURE REVIEW OF GENITAL PSORIASIS : SUCCESSFUL THERAPY WITH TACROLIMUS * (2014) (2)
- Inflammatory linear verrucous epidermal nevus and epilepsy: remission during valproic acid therapy. (2013) (2)
- Diagnosis and Treatment of Melanoma. European Consensus ⴀbased Interdisciplinary Guideline Developed by the Guideline Subcommittee of the (2012) (2)
- Treatment of disfiguring chronic graft versus host disease in a child with topical pimecrolimus (2009) (2)
- Patients with Psoriasis Vulgaris Streptococcal Angina and Skin Lesions of -Chain Rearrangements in β Identical TCR (2013) (2)
- Use of recombinant interferon alpha-2a in the treatment of squamous cell carcinoma (1995) (2)
- The Spectrum of Photodamage and its Treatment (1995) (1)
- Abstracts from the 4th World Congress of the International Dermoscopy Society, April 16–18, 2015, Vienna, Austria (2015) (1)
- Linee guida in dermoscopia (2005) (1)
- CDKN2A alterations in patients with multiple primary melanomas (2002) (1)
- 308 nm monochromatic excimer light in the treatment of psoriasis (2008) (1)
- Insight into genetics of atopic dermatitis: future approaches and directions. (2003) (1)
- Clonality in sarcoidosis , granuloma annulare , and granulomatous mycosis fungoides (1)
- Skin Lesion: unexpected uptake PET/CT (2015) (1)
- Quality of Life Evaluation in Psoriasis Patients Starting a Biological Treatment: The Importance of a More Comprehensive Assessment of Disease Burden (2015) (1)
- p63 and IRF6 are components of a common molecular pathway disrupted in ectodermal dysplasias (2010) (1)
- New therapeutic approaches in the treatment of anogenital lichen sclerosus: does PDT represent a novel option? (2015) (1)
- Skin diseases in Europe. Dermatooncology. (2009) (1)
- calcitriol in the Management of Moderate to severe plaque psoriasis (2009) (1)
- CO-30 antigen - An immunohistochemical marker for the diagnosis of lymphomatoid papulosis and cutaneous Hodgkin's disease CD-30 ANTIGEN - EIN IMMUNHISTOCHEMISCHER MARKER ZUR DIAGNOSE DER LYMPHOMATOIDEN PAPULOSE UND DES KUTANEN MORBUS HODGKIN (1989) (1)
- Recent patents on melanoma with focus on genetic strategies. (2008) (1)
- Dermoscopy of pigmented skin lesions. Results of an Internet study of 148 pigmented skin lesions evaluated by 40 experts (2002) (1)
- In Memoriam / Announcements (1999) (1)
- Primary cutaneous B-cell lymphoma - Reply (2006) (1)
- Effectiveness of Imiquimod on Molluscum Contagiosum Viral Chemokines (2007) (1)
- Reply to Scalone and Cortesi: “Cost-Utility Analysis of Biologic Therapies to Treat Chronic Plaque Psoriasis in Italy: The Importance of Using Updated and Adequate Social Tariffs to Calculate QALYs” (2015) (1)
- [Therapeutic activity of aminaphthone in purpuric disorders]. (1978) (1)
- Prognostic-Significance of Plasma-Cell Infiltrates in Cutaneous T-Cell Lymphomas (1987) (1)
- Primary Cutaneous Immunocytoma: Presentation of Six Cases. (1999) (1)
- IL-21, a new player in pathogenesis of psoriasis (2009) (1)
- [Immunophenotype of lymphocytic infiltrate in mycosis fungoides at the plaque stage and at the tumor stage. A comparative study]. (1990) (1)
- Some considerations about the importance of alliance between patients and dermatologists in psoriasis (2014) (1)
- Synovial sarcoma of the foot. (1982) (1)
- Reply to Scalone and Cortesi: “Cost-Utility Analysis of Biologic Therapies to Treat Chronic Plaque Psoriasis in Italy: The Importance of Using Updated and Adequate Social Tariffs to Calculate QALYs” (2015) (1)
- Therapeutics Efficacy of monochromatic excimer laser radiation (308 nm) in the treatment of early stage mycosis fungoides (2004) (0)
- Primary cutaneous B-cell lymphoma. Authors' reply (2006) (0)
- Acknowledgment to Referees for Dermatology 2001 (2001) (0)
- PSS28 Long-Term Improvement in Patient-Reported Outcomes After Transition From Methotrexate to Ustekinumab in Moderate to Severe Psoriasis: Transit Week 52 Results (2012) (0)
- P400 Psoriasis phenotype in inflammatory bowel disease (2013) (0)
- A Special Issue of Dermatology Dedicated to Theo Rufli (2005) (0)
- Assessing the expression of HLA-Cw6 using specific single chain antibody (scFv) (2008) (0)
- Subject Index Vol. 216, 2008 (2008) (0)
- Ef® cacy Evaluation of an Oil-in-Water Emulsion (Dermo ̄ an) in Atopic Dermatitis (2003) (0)
- A new bidimensional approach for pigmented skin lesions: hypo-epiluminescence microscopy 1 1 Disclosure not available at press time. (2004) (0)
- 031 Experimental therapeutic melanoma vaccination by ECP-generated dendritic cells (2016) (0)
- Genetic alterations in patients with multiple melanomas (2002) (0)
- Association analysis of the loricrin gene in Italian patients with psoriasis. (2002) (0)
- Emerging treatments in the management of psoriasis: biological targeting with ustekinumab (2009) (0)
- Influence and variation of the body mass index in patients treated with etancercept for psoriasis (2007) (0)
- Journal Of Cutaneous Pathology Index (2004) (0)
- P.01.19 PSORIASIS PHENOTYPE IN INFLAMMATORY BOWEL DISEASE (2013) (0)
- DOP066 Psoriasis phenotype in inflammatory bowel disease: a case-control prospective longitudinal study (2014) (0)
- Granular cell dermatofibroma Dermatofibroma a cellule granulose (1999) (0)
- Nevo di Reed e melanoma: analisi dermoscopica digitale (2000) (0)
- Contents Vol. 61, 2006 (2006) (0)
- Mo1244 Psoriasis Phenotype in Inflammatory Bowel Disease (2013) (0)
- [Analysis of point mutations of Ha-ras gene in basaliomas and spinaliomas usiang the polymerase chain reaction (PCR) technic]. (1989) (0)
- Newsletter No. 10/2010 (2010) (0)
- Imiquimod 5% cream for the treatment of cutaneous epithelial neoplasms1 (2004) (0)
- Meetings, Transactions and Society News (2005) (0)
- Onset of actinic Keratosis on squamous cell carcinoma succesfully treated with superficial Radiotherapy (2006) (0)
- Acknowledgement to Referees for Dermatology 2008 (2008) (0)
- SNPing of LOR genes in psoriasis patients. (2002) (0)
- Newsletter No. 4/2009 (2008) (0)
- Psoriasis disappearance after resection of a bladder tumour. (2010) (0)
- Mycosis fungoides in the setting of T-cell large granular lymphocyte proliferative disorder. (2012) (0)
- Linfomi primitivi cutanei a fenotipo B (1999) (0)
- Etanercept reverses downregulation of inhibitor of nuclear factor kappa-B kinase subunit alpha (IKKa) in psoriasis (2013) (0)
- P298 Analysis of p16INK4a and p19ARF germline mutations in familial melanoma (1997) (0)
- [Ashy dermatosis: clinico-pathological associations in two cases]. (2008) (0)
- Chairman of EDF Guideline Commitee (2006) (0)
- Contents Vol. 203, 2001 (2001) (0)
- In fl iximab in the treatment of plaque type psoriasis (2009) (0)
- Calcipotriene/betamethasonein thetreatmentofpsoriasis: areviewarticle (2009) (0)
- Contents Vol. 216, 2008 (2008) (0)
- Long-term safety and tolerability of Apremilast in patients with psoriasis: pooled safety analysis of the ESTEEM 1 and 2 trials (2015) (0)
- P.04.11 SPECIFIC PSORIASIS PHENOTYPES ASSOCIATED WITH INFLAMMATORY BOWEL DISEASE: A MONOCENTRIC PROSPECTIVE CASE-CONTROL STUDY (2014) (0)
- The Cost Effectiveness of Biologic Therapy for the Treatment of Chronic Plaque Psoriasis in Real Practice Settings in Italy (2014) (0)
- Subject Index Vol. 61, 2006 (2006) (0)
- CUTANEOUS METASTASES OF GASTROINTESTINAL MALIGNANCIES (1998) (0)
- ILDS Newsletter No. 27 (2013) (0)
- Adipose tissue response to IL-17 combined with TNF-alpha exposure (2014) (0)
- Plenary sessions: introduction (2008) (0)
- Germline and somatic CDKN2A mutations in multiple primary melanoma patients. (2000) (0)
- Book Review / Announcement (2001) (0)
- Contents Vol. 225, 2012 (2013) (0)
- Next generation sequencing technology to explore anti-inflammatory activity of IKKa in psoriasis (2012) (0)
- P.04.4 SCREENING FOR MELANOMA AND NON MELANOMA SKIN CANCER IN IBD PATIENTS BEFORE TREATMENT WITH THIOPURINES AND ANTI-TNFs: A PROSPECTIVE COHORT STUDY (2014) (0)
- [On the use in dermatological patients of a macrolide antibiotic: triacetyloleandomycin (author's transl)]. (1973) (0)
- Nanomedicine in Dermatology: Benefits and Emerging Applications (2012) (0)
- HOW TO USE THE ABSTRACTS OF THE EUROPEAN CONGRESS ON PSORIASIS (2004) (0)
- Subject Index Vol. 217, 2008 (2008) (0)
- Cw6 but not allele LCE3C_LCE3B deletion confers sensitivity to ustekinumab treatment in psoriasis (2012) (0)
- P352 Screening for melanoma and non melanoma skin cancer in IBD patients before treatment with thiopurines and anti-TNFs: A prospective cohort study (2014) (0)
- HLA-C*18:01: A Rare Allele in the European Caucasian Population Coinciding with Difficult-to-Treat Plaque Psoriasis (2016) (0)
- Treatment of actinic cheilitis with tazarotene 0.05% gel (2006) (0)
- Contents Vol. 217, 2008 (2008) (0)
- Penile metastases from bladder carcinoma. (1996) (0)
- Classification of non-Hodgkin malignant lymphomas of the skin. (1986) (0)
- XV CONGRESS OF THE ITALIAN SOCIETY OF MYOLOGY Naples, Italy - May 20-23, 2015 - Program (Summary) (2015) (0)
- A new insight into our understanding of neurofibromatosis type 1? (2004) (0)
- Nanosilicon spray is a novel alternative treatment for mild plaque psoriasis (2008) (0)
- Efficacy of pamidronate disodium in a patient with Sézary syndrome and osteolytic bone metastases (1998) (0)
- USEFULNESS OF DERMOSCOPY FOR DETECTING SKIN LEIOMYOMAS IN PATIENT WITH UTERINE FIBROIDS AND CEREBRAL CAVERNOMAS (2014) (0)
- THERAPEUTIC HOTLINE Prospective assessment of body weight and body composition changes in patients with psoriasis receiving anti-TNF-a treatment (2011) (0)
- Topical use of valproic acid for the treatment of psoriasis and acne (2004) (0)
- Biopsy of sentinel lymph node for melanoma in Day Surgery (2009) (0)
- Subject Index Vol. 203, 2001 (2001) (0)
- A case of pemphigus foliaceus successfully treated with anti-Ig-Ab immunoadsorption. (2013) (0)
- POLYMERASE CHAIN REACTION ANALYSIS OF EPSTEINBARR VIRUS, CYTOMEGALOVIRUS AND HERPES SIMPLEX VIRUS DNA GENOME IN CUTANEOUS AND NODAL LESIONS OF ANAPLASTIC LARGE-CELL LYMPHOMAS (1994) (0)
- Electrochemotherapy in the treatment of cutaneous and subcutaneous neoplasms (2012) (0)
- 469 Experimental T cells immunotherapy by tumor-loaded ECP-generated dendritic antigen presenting cells (2016) (0)
- Imiquimod 5% cream for the treatment of cutaneous epithelial neoplasms 1 1 The authors have no financial interest. (2004) (0)
- Anti-inflammatory activity of IKKa in psoriasis explored by ChIP-sequencing (2012) (0)
- Teledermatoscopy. Results of a multicentric study on pigmented skin lesions Teledermoscopia. Risultati di uno studio multicentrico sulle lesioni pigmentate cutanee (2000) (0)
- Contents Vol. 229, 2014 (2014) (0)
- P-531: Cyclosporine administration in psoriasis reversibly induces hypertension with autonomic and endothelial dysfunction (2002) (0)
- ILDS Newsletter No. 31 (2014) (0)
- Mo1192 Psoriasis Phenotype in Inflammatory Bowel Disease: A Case-Control Prospective Study (2014) (0)
- Proteus syndrome is a rare and complex congenital hamartomatous disorder with multi-organ involvement (0)
- detection of point mutations of Ha-ras gene in basaliomas and spinaliomas by the use of polymerase chain reaction (PCR) ANALISI DELLE MUTAZIONI PUNTIFORMI DEL GENE HA-RAS IN BASALIOMI E SPINALIOMI MEDIANTE LA TECNICA DELLA POLYMERASE CHAIN REACTION (PCR) (1989) (0)
- Newsletter No. 6/2009 (2009) (0)
- S077 Mycosis fungoides: From clinical aspects to molecular biology (1997) (0)
- Contents Vol. 227, 2013 (2014) (0)
- Severe erytrodermic psoriasis in child twins: from clinical-pathological diagnosis to treatment of choice through genetic analyses: two case reports (2014) (0)
- Reproducibility of Saida's classification for acral pigmented skin lesions through a teledermoscopic study (2002) (0)
- Analysis of genetic instability (“microsatellites”) in malignant melanoma (1994) (0)
- Unusual case of mycosis fungoides clinically mimicking a dermatophytosis subsequently evolving in aggressive CD30- cutaneous lymphoma (2006) (0)
- Genetic Markers for Cardiovascular Disease in Psoriasis: The Missing Piece (2013) (0)
- Sentinel lymph node biopsy for cutaneous melanoma in day surgery (2012) (0)
- Investigating the expression of the susceptibility allele HLA-Cw6 in psoriasis using a specific single chain fragment antibody (2008) (0)
- Validity of teledermoscopy in the clinical management of patients with multiple atypical pigmented skin lesions (2002) (0)
- Serum Protein Profile Changes in Psoriatic Patients Undergoing Treatment With Infliximab. (2016) (0)
- 1st Winter Academy of Dermatology (2008) (0)
- A new bidimensional approach for pigmented skin lesions: hypo-epiluminescence microscopy1 (2004) (0)
- CD-30 Expression in Inflammatory and Lymphoproliferative Skin Diseases (1989) (0)
- CLINICAL EFFICACY AND SAFETY OF A COMBINED FORMULATION OF ZINC PYRITHIONE 0 . 25 % AND BETAMETHASONE DIPROPIONATE MICRONIZED 0 . 05 % IN THE TREATMENT OF MILD TO MODERATE PLAQUE PSORIASIS (2011) (0)
- Newsletter No. 17 (2011) (0)
- Is there a link between chronic urticaria and atopy ? (2008) (0)
- Kaposi's sarcoma. (1984) (0)
- Biologic Therapies For Psoriasis (2009) (0)
- Lung nodule and facial erythematous plaques: a quiz. (2013) (0)
- Analysis of risk factors in cutaneous malignant melanoma: an italian population-based study (2009) (0)
- Keratosis punctata palmoplantaris and malignancies: case report (2006) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Sergio Chimenti?
Sergio Chimenti is affiliated with the following schools:
